Appropriate and timely antimicrobial therapy in cirrhotic patients with spontaneous bacterial peritonitis-associated septic shock: a retrospective cohort study
Appropriate and timely antimicrobial therapy in cirrhotic patients with spontaneous bacterial peritonitis-associated septic shock: a retrospective cohort study
复制标题
DOI:
10.1111/apt.13135
复制
发表时间:
2015-04-01
影响因子:
7.6
通讯作者:
Kumar, A.
中科院分区:
文献类型:
--
作者:
Karvellas, C. J.;Abraldes, J. G.;Kumar, A.
BackgroundSpontaneous bacterial peritonitis (SBP)-associated septic shock carries significant mortality in cirrhosis.AimTo determine whether practice-related aspects of antimicrobial therapy contribute to high mortality.MethodsRetrospective cohort study of all (n=126) cirrhotics with spontaneous bacterial peritonitis (neutrophil count >250 or positive ascitic culture)-associated septic shock (1996-2011) from an international, multicenter database. Appropriate antimicrobial therapy implied either in vitro activity against a subsequently isolated pathogen (culture positive) or empiric management consistent with broadly accepted norms (culture negative).ResultsOverall hospital mortality was 81.8%. Comparing survivors (n=23) with non-survivors (n=103), survivors had lower Acute Physiology and Chronic Health Evaluation (APACHEII) (means.d.; 22 +/- 7 vs. 32 +/- 8) and model for end-stage liver disease (MELD) (24 +/- 9 vs. 34 +/- 11) scores and serum lactate on admission (4.9 +/- 3.1 vs. 8.9 +/- 5.3), P